AR012448A1 - Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada - Google Patents
Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevadaInfo
- Publication number
- AR012448A1 AR012448A1 ARP980101756A ARP980101756A AR012448A1 AR 012448 A1 AR012448 A1 AR 012448A1 AR P980101756 A ARP980101756 A AR P980101756A AR P980101756 A ARP980101756 A AR P980101756A AR 012448 A1 AR012448 A1 AR 012448A1
- Authority
- AR
- Argentina
- Prior art keywords
- substance
- mixture
- polymer
- active
- microcapsules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
Abstract
La invencion se refiere a composiciones en forma de micro-cápsulas o implantes, que comprende un excipiente polimérico o copolimérico, bio-degradable, o una mezcla de dichos excipientes, con una viscosidad inherente de entre 0,5 dl/g y 1,6 dg/l en CHCl3, y una sustancia activa o una mezcla desustancias activas, siendo posible que dichas microcápsulas o implantes liberen la sustancia activa, o mezcla de sustancias activas, a lo largo de unprolongado período, de hasta tres meses o más. Dichas composiciones también pueden contener un principio activo de elevada área superficial específica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704837A FR2762318B1 (fr) | 1997-04-18 | 1997-04-18 | Compositions presentant une liberation prolongee et leur procede de preparation |
FR9803666A FR2776516B1 (fr) | 1998-03-25 | 1998-03-25 | Compositions presentant une liberation prolongee et leur procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012448A1 true AR012448A1 (es) | 2000-10-18 |
Family
ID=26233477
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101756A AR012448A1 (es) | 1997-04-18 | 1998-04-16 | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
ARP070102999A AR061828A2 (es) | 1997-04-18 | 2007-07-05 | Procedimiento para la preparacion de una sustancia soluble en agua de elevada area superficial especifica |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070102999A AR061828A2 (es) | 1997-04-18 | 2007-07-05 | Procedimiento para la preparacion de una sustancia soluble en agua de elevada area superficial especifica |
Country Status (23)
Country | Link |
---|---|
US (2) | US6217893B1 (es) |
EP (1) | EP0980240B1 (es) |
JP (1) | JP4557312B2 (es) |
CN (2) | CN1144584C (es) |
AR (2) | AR012448A1 (es) |
AT (1) | ATE389388T1 (es) |
AU (1) | AU741964B2 (es) |
BR (1) | BR9808933A (es) |
CA (1) | CA2286575C (es) |
CZ (1) | CZ297078B6 (es) |
DE (1) | DE69839264T2 (es) |
DK (1) | DK0980240T3 (es) |
ES (1) | ES2303353T3 (es) |
HK (1) | HK1027983A1 (es) |
HU (1) | HUP0004297A2 (es) |
IL (1) | IL132217A (es) |
MY (1) | MY118835A (es) |
NO (2) | NO327999B1 (es) |
PL (1) | PL196771B1 (es) |
PT (1) | PT980240E (es) |
RU (1) | RU2198678C2 (es) |
TW (1) | TW577759B (es) |
WO (1) | WO1998047489A1 (es) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
MY118835A (en) * | 1997-04-18 | 2005-01-31 | Ipsen Pharma Biotech | Sustained release compositions and the process for their preparation |
US6303138B1 (en) | 1999-09-17 | 2001-10-16 | Depuy Orthopaedics | Endothelin-based compositions for enhancing connective tissue repair |
EP1832599A3 (en) * | 2000-04-12 | 2007-11-21 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
EP1381394A2 (en) * | 2001-04-17 | 2004-01-21 | The University Of Sheffield | Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming |
EP1401477A4 (en) * | 2001-05-25 | 2005-02-02 | Human Genome Sciences | CHIMIOKINE BETA-1 HYBRID PROTEINS |
WO2003000156A1 (en) * | 2001-06-22 | 2003-01-03 | Southern Biosystems, Inc. | Zero-order prolonged release coaxial implants |
GB0122113D0 (en) * | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Composition |
WO2003059934A2 (en) * | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP2277910A1 (en) * | 2001-12-21 | 2011-01-26 | Human Genome Sciences, Inc. | Albumin fusion proteins |
MXPA05002991A (es) * | 2002-09-18 | 2005-10-05 | Univ Montreal Ct Hospitalier Chum | Analogos de ghrh. |
US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
MXPA05006994A (es) * | 2002-12-27 | 2005-10-18 | Diobex Inc | Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina. |
WO2004087102A2 (en) * | 2003-03-26 | 2004-10-14 | Teva Pharmaceutical Industries Ltd. | A process for preparing a pharmaceutical active ingredient with high specific surface area |
US20070027073A1 (en) * | 2003-04-08 | 2007-02-01 | Menachem Rubinstein | Long-acting derivatives of pyy agonists |
US20070207211A1 (en) * | 2003-04-10 | 2007-09-06 | Pr Pharmaceuticals, Inc. | Emulsion-based microparticles and methods for the production thereof |
ES2427092T3 (es) * | 2003-04-10 | 2013-10-28 | Evonik Corporation | Un método para la producción de micropartículas a base de emulsión |
EP1620060B1 (en) | 2003-04-29 | 2010-03-24 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
WO2005009356A2 (en) * | 2003-07-15 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Method for the preparation of controlled release formulations |
CN100588423C (zh) * | 2003-07-23 | 2010-02-10 | Pr药品有限公司 | 控释组合物 |
KR100725315B1 (ko) * | 2003-11-13 | 2007-06-07 | 한미약품 주식회사 | 면역글로불린 단편을 이용한 단백질 결합체 및 그의제조방법 |
AU2004313245B2 (en) | 2003-12-30 | 2011-04-14 | Durect Corporation | Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH |
SI2409707T1 (sl) | 2004-04-15 | 2015-07-31 | Alkermes Pharma Ireland Limited | Naprava s podaljšanim sproščanjem na osnovi polimerov |
US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
US7264314B2 (en) | 2004-10-27 | 2007-09-04 | Brennan Miles B | Adrenocorticotropic hormone analogs and related methods |
EP1679065A1 (en) * | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Controlled release compositions for interferon based on PEGT/PBT block copolymers |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
US20080138431A1 (en) * | 2005-03-02 | 2008-06-12 | James Edward Eyles | Pharmaceutical Composition |
US7942867B2 (en) * | 2005-11-09 | 2011-05-17 | The Invention Science Fund I, Llc | Remotely controlled substance delivery device |
CA2631811C (en) * | 2005-12-22 | 2017-06-20 | Novartis Ag | Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
SI1984009T1 (sl) * | 2006-01-18 | 2013-02-28 | Qps, Llc | Farmacevtski sestavki z izboljĺ ano stabilnostjo |
EP1837014A1 (en) * | 2006-03-21 | 2007-09-26 | Hexal Ag | Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue |
DK2359808T3 (da) | 2006-08-09 | 2013-08-05 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelaggregater |
AU2008231093A1 (en) * | 2007-03-22 | 2008-10-02 | Alkermes, Inc. | Coacervation process |
MX2009011123A (es) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Formulaciones de suspensiones de peptidos insulinotropicos y sus usos. |
EP2500014B1 (en) | 2007-06-06 | 2018-08-08 | Debiopharm Research & Manufacturing SA | Slow release pharmaceutical composition made of microparticles |
US20080317865A1 (en) * | 2007-06-20 | 2008-12-25 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
KR101921800B1 (ko) * | 2008-01-30 | 2018-11-23 | 노파르티스 아게 | 옥트레오티드 및 3종의 선형 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제 |
CA2726861C (en) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
PL2341905T5 (pl) * | 2008-09-04 | 2024-01-15 | Amylin Pharmaceuticals, Llc | Preparaty o przedłużonym uwalnianiu z wykorzystaniem niewodnych nośników |
ES2650667T3 (es) | 2009-09-28 | 2018-01-19 | Intarcia Therapeutics, Inc | Rápido establecimiento y/o terminación de la administración sustancial de fármaco en estado estacionario |
USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
PT3536333T (pt) * | 2010-01-04 | 2022-11-11 | Mapi Pharma Ltd | Sistema de depósito compreendendo acetato de glatirâmero |
IT1402654B1 (it) * | 2010-09-20 | 2013-09-13 | Cid S R L | Composizione per il rilascio di principi attivi da dispositivi di impianto |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
CN103163258B (zh) * | 2011-12-09 | 2015-09-23 | 山东绿叶制药有限公司 | 一种测定痕量曲普瑞林的方法 |
CN102552166A (zh) * | 2012-01-09 | 2012-07-11 | 北京化工大学 | 一种溶菌酶/聚(α-氰基丙烯酸异丁酯)载药微球的制备方法 |
ES2692949T3 (es) * | 2012-03-08 | 2018-12-05 | Consejo Superior De Investigaciones Científicas (Csic) | Recubrimiento con propiedades fotocrómicas, método de obtención de dicho recubrimiento y uso aplicable a artículos ópticos y superficies acristaladas |
BR112014026957A8 (pt) | 2012-05-03 | 2018-01-16 | Janssen R&D Ireland | micropartícula, composição compreendendo a mesma, seu uso e sistema de distribuição nasal relacionados ao tratamento de infecções do trato respiratório superior |
RU2506269C1 (ru) * | 2012-08-03 | 2014-02-10 | Татьяна Георгиевна Емельянова | Фармацевтическая композиция, содержащая физиологически активные гептапептиды, обладающие противосудорожным, анксиолитическим, центральным противовоспалительным и анальгетическим, а также антиалкогольным действием |
ES2716384T3 (es) * | 2013-04-18 | 2019-06-12 | Shandong luye pharmaceutical co ltd | Composición farmacéutica de microesferas de liberación sostenida de goserelina |
CN103230624A (zh) * | 2013-05-02 | 2013-08-07 | 复旦大学附属上海市第五人民医院 | 一种用于微创埋线治疗的植入材料 |
CN103720663B (zh) * | 2014-01-08 | 2016-04-06 | 昆药集团股份有限公司 | 一种促卵泡激素缓释微球及其制备方法 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US20160106804A1 (en) * | 2014-10-15 | 2016-04-21 | Yuhua Li | Pharmaceutical composition with improved stability |
MA44390A (fr) | 2015-06-03 | 2019-01-23 | Intarcia Therapeutics Inc | Systèmes de mise en place et de retrait d'implant |
EP3307247A1 (en) * | 2015-06-10 | 2018-04-18 | Evonik Röhm GmbH | Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer |
CN107224571A (zh) * | 2016-03-23 | 2017-10-03 | 张巍 | 一种具有坐骨神经保护功能的plga复合微球 |
ITUA20162094A1 (it) | 2016-03-29 | 2017-09-29 | Cid S P A | Perfezionamenti negli stent per il rilascio di principi attivi |
CN105963258B (zh) | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
US10835580B2 (en) | 2017-01-03 | 2020-11-17 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
US11167003B2 (en) | 2017-03-26 | 2021-11-09 | Mapi Pharma Ltd. | Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems |
CN107375910B (zh) * | 2017-07-12 | 2020-03-24 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | PTHrP在制备治疗男性性腺功能低下综合征中的应用 |
CN110547969A (zh) * | 2019-09-03 | 2019-12-10 | 杭州诺泰澳赛诺医药技术开发有限公司 | 一种高比表面积纳米级缓释微粉的生产工艺及设备 |
IT202000017191A1 (it) * | 2020-07-15 | 2022-01-15 | Xbrane Biopharma Ab | Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale |
CN112156170B (zh) * | 2020-11-03 | 2022-10-21 | 北京康欣东弘医药科技有限公司 | 可供皮下注射的曲普瑞林缓释微球及其制备方法和用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH661206A5 (fr) * | 1983-09-23 | 1987-07-15 | Debiopharm Sa | Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes. |
CN100391445C (zh) * | 1996-01-24 | 2008-06-04 | 美国政府陆军部 | 新型的“非突发的”持续释放聚(丙交酯/乙交酯)的微球 |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
DE3734223A1 (de) * | 1987-10-09 | 1989-04-20 | Boehringer Ingelheim Kg | Implantierbares, biologisch abbaubares wirkstofffreigabesystem |
US5021554A (en) * | 1989-02-24 | 1991-06-04 | Eli Lilly And Company | Process for protein particle size reduction using a fluid-energy mill |
GB2246514B (en) | 1990-08-01 | 1993-12-15 | Scras | Sustained release pharmaceutical compositions and the preparation of particles for use therein |
GB9016885D0 (en) * | 1990-08-01 | 1990-09-12 | Scras | Sustained release pharmaceutical compositions |
DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
DE4223169C1 (de) * | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe |
FR2693905B1 (fr) * | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
WO1994015587A2 (en) * | 1993-01-06 | 1994-07-21 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
US5785976A (en) * | 1993-03-05 | 1998-07-28 | Pharmacia & Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
US6117455A (en) | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
US6136346A (en) * | 1995-04-14 | 2000-10-24 | Inhale Therapeutic Systems | Powdered pharmaceutical formulations having improved dispersibility |
CA2223436A1 (en) * | 1995-06-07 | 1996-12-19 | Alkermes Controlled Therapeutics Inc. | Composition for sustained release of human growth hormone |
MY118835A (en) * | 1997-04-18 | 2005-01-31 | Ipsen Pharma Biotech | Sustained release compositions and the process for their preparation |
-
1998
- 1998-04-16 MY MYPI98001698A patent/MY118835A/en unknown
- 1998-04-16 TW TW087105802A patent/TW577759B/zh not_active IP Right Cessation
- 1998-04-16 AR ARP980101756A patent/AR012448A1/es not_active Application Discontinuation
- 1998-04-17 WO PCT/FR1998/000773 patent/WO1998047489A1/fr active IP Right Grant
- 1998-04-17 CN CNB988052202A patent/CN1144584C/zh not_active Expired - Fee Related
- 1998-04-17 RU RU99124209/14A patent/RU2198678C2/ru not_active IP Right Cessation
- 1998-04-17 EP EP98921551A patent/EP0980240B1/fr not_active Revoked
- 1998-04-17 CN CNB031545998A patent/CN1313082C/zh not_active Expired - Fee Related
- 1998-04-17 JP JP54515098A patent/JP4557312B2/ja not_active Expired - Fee Related
- 1998-04-17 US US09/403,058 patent/US6217893B1/en not_active Expired - Lifetime
- 1998-04-17 CA CA2286575A patent/CA2286575C/fr not_active Expired - Fee Related
- 1998-04-17 ES ES98921551T patent/ES2303353T3/es not_active Expired - Lifetime
- 1998-04-17 DE DE69839264T patent/DE69839264T2/de not_active Expired - Lifetime
- 1998-04-17 DK DK98921551T patent/DK0980240T3/da active
- 1998-04-17 HU HU0004297A patent/HUP0004297A2/hu unknown
- 1998-04-17 CZ CZ0362699A patent/CZ297078B6/cs not_active IP Right Cessation
- 1998-04-17 AU AU74363/98A patent/AU741964B2/en not_active Ceased
- 1998-04-17 AT AT98921551T patent/ATE389388T1/de active
- 1998-04-17 PL PL336296A patent/PL196771B1/pl unknown
- 1998-04-17 IL IL13221798A patent/IL132217A/en not_active IP Right Cessation
- 1998-04-17 PT PT98921551T patent/PT980240E/pt unknown
- 1998-04-17 BR BR9808933-1A patent/BR9808933A/pt not_active Application Discontinuation
-
1999
- 1999-10-15 NO NO19995063A patent/NO327999B1/no not_active IP Right Cessation
-
2000
- 2000-11-06 US US09/707,372 patent/US6475507B1/en not_active Expired - Lifetime
- 2000-11-23 HK HK00107498A patent/HK1027983A1/xx not_active IP Right Cessation
-
2007
- 2007-07-05 AR ARP070102999A patent/AR061828A2/es not_active Application Discontinuation
-
2008
- 2008-02-14 NO NO20080803A patent/NO20080803L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012448A1 (es) | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada | |
CA2382540A1 (en) | High viscosity liquid composition for the delivery of substances | |
CA2348016A1 (en) | Controlled release liquid delivery compositions with low initial drug burst | |
DE60017956D1 (de) | Biodegradierbare polymerzusammensetzung | |
CA2430481A1 (en) | Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof | |
DE69721481D1 (de) | Wirkstoffformulierungen mit verzögerter freisetzung | |
DK0643963T3 (da) | Biologisk nedbrydelig indretning til indgivelse af virksomme stoffer | |
BR9815239B1 (pt) | composição de liberação de droga polimérica biodegradável aquosa compreendendo um polìmero tribloco biodegradável do tipo aba- ou bab. | |
AR008060A1 (es) | Una formulacion no acuosa de peptidos y un metodo para prepararla | |
WO2001091725A3 (en) | Biologically useful polyphosphates | |
DE69121675D1 (de) | Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung | |
BG104838A (en) | Liquid polymeric compositions for controlled release of bioactive substances | |
BRPI0012588B8 (pt) | copolímero em bloco, composição para suprimento de agente bioativo, e, formulação de medicamento para implantação subcutânea ou injeção intravenosa. | |
CA2315115A1 (en) | Compositions of microspheres for wound healing | |
EP0359402A3 (en) | Long lasting contraceptive suppository composition and methods of use | |
GR3030732T3 (en) | Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent. | |
BR9814756A (pt) | Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis | |
ATE217532T1 (de) | Eine didemnin verbindung enthaltende pharmazeutische formulierung | |
ES2127556T3 (es) | Cuerpo de moldeo implantable para la administracion de sustancias activas a plantas. | |
CO5170438A1 (es) | Proceso para la preparacion de un comprimido de betahistina de liberacion controlada por granulacion en estado fundido y comprimido de liberacion controlada de betahistina obtenido mediante dicho proceso | |
ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. | |
ATE258446T1 (de) | Benzophenanthridinalkaloid-enthaltende pestizide | |
UY26765A1 (es) | Composiciones de baja irritación | |
AU2002353661A1 (en) | Biodegradable polymeric material for biomedical applications | |
DK1484033T3 (da) | Flydende polymersammensætninger til kontrolleret frigivelse af bioaktive stoffer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |